Spain · Delayed Price · Currency is EUR Natac Natural Ingredients Statistics
Total Valuation
BME:NAT has a market cap or net worth of EUR 364.71 million. The enterprise value is 421.60 million.
| Market Cap | 364.71M |
| Enterprise Value | 421.60M |
Important Dates
The next estimated earnings date is Friday, November 28, 2025.
| Earnings Date | Nov 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BME:NAT has 431.61 million shares outstanding. The number of shares has increased by 1,043.57% in one year.
| Current Share Class | 431.61M |
| Shares Outstanding | 431.61M |
| Shares Change (YoY) | +1,043.57% |
| Shares Change (QoQ) | -28.05% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.21% |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 917.59 and the forward PE ratio is 84.50.
| Price/FFO Ratio | n/a |
| Price/AFFO Ratio | n/a |
| PE Ratio | 917.59 |
| Forward PE | 84.50 |
| PS Ratio | 10.21 |
| PB Ratio | 8.54 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 38.69 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 85.01, with an EV/FCF ratio of -227.77.
| EV / Earnings | 1,060.72 |
| EV / Sales | 11.81 |
| EV / EBITDA | 85.01 |
| EV / EBIT | n/a |
| EV / FCF | -227.77 |
Financial Position
The company has a current ratio of 0.66, with a Debt / Equity ratio of 1.35.
| Current Ratio | 0.66 |
| Quick Ratio | 0.22 |
| Debt / Equity | 1.35 |
| Debt / EBITDA | 11.59 |
| Debt / FCF | -31.04 |
| Interest Coverage | 0.29 |
Financial Efficiency
Return on equity (ROE) is 0.92% and return on invested capital (ROIC) is 0.78%.
| Return on Equity (ROE) | 0.92% |
| Return on Assets (ROA) | 0.60% |
| Return on Invested Capital (ROIC) | 0.78% |
| Return on Capital Employed (ROCE) | 1.36% |
| Revenue Per Employee | 208,811 |
| Profits Per Employee | 2,324 |
| Employee Count | 171 |
| Asset Turnover | 0.27 |
| Inventory Turnover | 0.59 |
Taxes
| Income Tax | -149,350 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +32.03% in the last 52 weeks. The beta is -0.41, so BME:NAT's price volatility has been lower than the market average.
| Beta (5Y) | -0.41 |
| 52-Week Price Change | +32.03% |
| 50-Day Moving Average | 0.88 |
| 200-Day Moving Average | 0.74 |
| Relative Strength Index (RSI) | 43.31 |
| Average Volume (20 Days) | 34,415 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:NAT had revenue of EUR 35.71 million and earned 397,467 in profits. Earnings per share was 0.00.
| Revenue | 35.71M |
| Gross Profit | 25.44M |
| Operating Income | 1.26M |
| Pretax Income | 248,117 |
| Net Income | 397,467 |
| EBITDA | 4.75M |
| EBIT | 1.26M |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 568,983 in cash and 57.46 million in debt, giving a net cash position of -56.89 million or -0.13 per share.
| Cash & Cash Equivalents | 568,983 |
| Total Debt | 57.46M |
| Net Cash | -56.89M |
| Net Cash Per Share | -0.13 |
| Equity (Book Value) | 42.70M |
| Book Value Per Share | 0.10 |
| Working Capital | -14.53M |
Cash Flow
In the last 12 months, operating cash flow was 9.43 million and capital expenditures -11.28 million, giving a free cash flow of -1.85 million.
| Operating Cash Flow | 9.43M |
| Capital Expenditures | -11.28M |
| Free Cash Flow | -1.85M |
| FCF Per Share | -0.00 |
Margins
Gross margin is 71.25%, with operating and profit margins of 3.53% and 1.11%.
| Gross Margin | 71.25% |
| Operating Margin | 3.53% |
| Pretax Margin | 0.69% |
| Profit Margin | 1.11% |
| EBITDA Margin | 13.31% |
| EBIT Margin | 3.53% |
| FCF Margin | n/a |
Dividends & Yields
BME:NAT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1,043.57% |
| Shareholder Yield | -1,043.57% |
| Earnings Yield | 0.11% |
| FCF Yield | -0.51% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |